glp 1 inhibitors for weight loss More people with type diabetes are using GLP-1 drugs, study finds, despite limited evidence on safety or effectiveness GLP-1 Medications for Weight Loss:
Description
2025;135(21):e194751

About Resbiotic Nutrition, Inc

Diabetes 2015

In SURMOUNT-1, approximately 4.3-7.1% of participants discontinued due to side effects (dose-dependent), compared to 6.4% with liraglutide in the SCALE trials

Patients should be advised to report any suspected side effects via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or the Yellow Card app)
